Skip to main content

Oxford Cannabinoid Technologies "proceeding forward as planned" after review meeting

Oxford Cannabinoid Technologies Holdings PLC (LSE:OCTP, OTCQB:OCTHF) CEO Clarissa Sowemimo-Coker speaks to Proactive after announcing that a Research Ethics Committee (REC) review meeting for its lead programme OCT461201 has now taken place. Sowemimo-Coker says the company is "proceeding forward as planned" and has "hit the ground running" in 2023.

Contact Details

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com

Recent Quotes

View More
Symbol Price Change (%)
AMZN  231.19
-1.33 (-0.57%)
AAPL  273.04
-0.36 (-0.13%)
AMD  213.78
-1.21 (-0.56%)
BAC  55.41
-0.76 (-1.34%)
GOOG  313.29
-1.67 (-0.53%)
META  654.48
-8.81 (-1.33%)
MSFT  484.87
-2.84 (-0.58%)
NVDA  186.94
-3.59 (-1.88%)
ORCL  194.76
-3.23 (-1.63%)
TSLA  465.87
-9.32 (-1.96%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.